BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22002034)

  • 1. Use of octreotide in the treatment of chylothorax and chyloperitoneum.
    Pessotti CF; Jatene IB; Buononato PE; Elias PF; Pinto AC; Kok MF
    Arq Bras Cardiol; 2011 Aug; 97(2):e33-6. PubMed ID: 22002034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
    Mitchell K; Weiner A; Ramsay P; Sahni M
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous neonatal chylothorax treated with octreotide.
    Siu SL; Lam DS
    J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the treatment of congenital chylothorax.
    Rasiah SV; Oei J; Lui K
    J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chylothorax with octreotide after congenital heart surgery.
    Tatar T; Kilic D; Ozkan M; Hatipoglu A; Aslamaci S
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):298-301. PubMed ID: 21394709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
    Wright SB; Mainwaring RD
    J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylothorax in children after congenital heart surgery.
    Chan SY; Lau W; Wong WH; Cheng LC; Chau AK; Cheung YF
    Ann Thorac Surg; 2006 Nov; 82(5):1650-6. PubMed ID: 17062221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series.
    Shah D; Sinn JK
    Acta Paediatr; 2012 Apr; 101(4):e151-5. PubMed ID: 22092874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide treatment of chylothorax in pediatric patients following cardiothoracic surgery.
    Caverly L; Rausch CM; da Cruz E; Kaufman J
    Congenit Heart Dis; 2010; 5(6):573-8. PubMed ID: 21106017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe congenital chylothorax treated with octreotide.
    Young S; Dalgleish S; Eccleston A; Akierman A; McMillan D
    J Perinatol; 2004 Mar; 24(3):200-2. PubMed ID: 15044932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide treatment for chylothorax after congenital heart surgery.
    Tavli V; Yilmazer MM; Guven B; Mese T; Lafci B; Gurbuz A
    J Card Surg; 2009; 24(5):570-1. PubMed ID: 19740301
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide infusion for the treatment of chylothorax in pediatric cardiac intensive care unit.
    Yildirim SV; Kervancioğlu M; Saritaş B; Varan B; Mercan S; Tokel K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):317-8. PubMed ID: 16330401
    [No Abstract]   [Full Text] [Related]  

  • 14. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A; Magalotti D; Cocci C; Angeloni L; Pironi L; Zoli M
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide Use in Neonates: A Case Series.
    Zaki SA; Krishnamurthy MB; Malhotra A
    Drugs R D; 2018 Sep; 18(3):191-198. PubMed ID: 29948779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Pelletier GJ
    Ann Thorac Surg; 2006 Nov; 82(5):1656-7. PubMed ID: 17062222
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful management of chylous ascites with total parenteral nutrition and octreotide in children.
    Yang C; Zhang J; Wang S; Li CC; Kong XR; Zhao Z
    Nutr Hosp; 2013 Nov; 28(6):2124-7. PubMed ID: 24506391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
    Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
    Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.
    Namba M; Masuda T; Nakamura T; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Intern Med; 2017 Dec; 56(24):3327-3331. PubMed ID: 29021448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.